PDF Publication PDF Publication

Expert Perspectives in Individualized Contemporary Care for Short Bowel Syndrome


Released:
12/23/13
Expires:
12/22/14

Maximum Credits:

1.0

PDF Publication PDF Publication
Released:
12/23/13

Expires:
12/22/14

Maximum Credits:
1.0
PDF Publication PDF Publication

Released:
12/23/13
Expires:
12/22/14


Maximum Credits:
1.0


Overview: This publication, summarizing a roundtable discussion with 6 faculty experts, explores current perspectives in the management of short bowel syndrome (SBS). It covers topics such as clinical consequences, patient quality of life, and therapeutic advances and is designed to help clinicians understand malnutrition concerns, appreciate the process of intestinal adaptation, and optimally individualize therapy to mitigate the clinical and quality-of-life risks associated with the long-term use of parenteral nutrition.

CME Information:

Learning Objectives
Upon completion, participants should be able to:

  • Describe the relationship among SBS, malabsorption, malnutrition, and intestinal failure
  • Discuss the clinical consequences of SBS and complications associated with dependency on parenteral nutrition that negatively affect patient quality of life
  • Outline the efficacy and safety of therapeutic advances in the management of SBS

Faculty
Alan L. Buchman, MD, MSPH
Center for Gastroenterology and Nutrition
Skokie, IL

John K. DiBaise, MD
Professor of Medicine
College of Medicine
Mayo Clinic
Rochester, MN
Consultant, Division of Gastroenterology & Hepatology
Mayo Clinic
Scottsdale, AZ

Donald F. Kirby, MD
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Director, Center for Human Nutrition
Medical Director, Intestinal Transplant
Program Director, Nutrition Fellowship
Cleveland Clinic Foundation
Cleveland, OH

Stephen J.D. O’Keefe, MD, MSc, FRCP
Professor of Medicine
Medical Director, Small Intestinal Rehabilitation & Transplant Center
Nutrition Support Service
University of Pittsburgh
Pittsburgh, PA

Carol Rees Parrish, MS, RD
Nutritional Support Specialist
University of Virginia Health System Center
Charlottesville, VA

James S. Scolapio, MD
Professor of Medicine
Chief, Division of Gastroenterology
Program Director, Gastroenterology Fellowship
University of Florida College of Medicine
Jacksonville, FL

Activity Planners
Julie Blum, PhD
Clinical Content Manager
Med-IQ
Baltimore, MD

Lisa R. Rinehart, MS, ELS
Director, Editorial Services
Med-IQ
Baltimore, MD

Target Audience
This activity is intended for gastroenterologists.

Series Overview/Statement of Need
Patients with short bowel syndrome (SBS) experience significant maldigestion, malabsorption, and malnutrition and have an increased risk of mortality. This mortality risk can be reduced by individualizing care to maximize adaptation in the remaining bowel. Recent therapeutic advances may profoundly improve quality of life and outcomes for individuals with SBS, but a 2013 survey of gastroenterologists revealed that 25% were unable to recognize these recent advances. Of note, though, 63% of respondents expressed a high level of desire for education in this area. Thus, taking these educational needs into consideration, this activity is designed to raise awareness of the changing therapeutic landscape in SBS and help clinicians provide up-to-date evidence-based care.

Accreditation/Designation Statements
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Med-IQ designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners, physician assistants, and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.

Estimated Time to Complete This Activity
This CME activity consists of a 1.0-credit publication. To receive credit, complete the pre-survey, read the introductory CME material, read the publication, and complete the post-survey, evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.

Original Release Date: December 23, 2013
Expiration Date: December 22, 2014
Estimated Time to Complete This Activity: 1 hour

The surveys, evaluation, attestation, and post-test may be completed online by clicking the “Get Credit” button on the Med-IQ activity Web page.

Disclosure Policy
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.

Disclosure Statement
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.

Alan L. Buchman, MD, MSPH, has indicated no real or apparent conflicts.

John K. DiBaise, MD
Contracted research: GI Dynamics, Given Imaging Ltd., Takeda Pharmaceuticals North America, Inc.

Donald F. Kirby, MD
Consulting fees/advisory boards: Luitpold Pharmaceuticals, Inc., NPS Pharmaceuticals, Inc.

Stephen J.D. O’Keefe, MD, MSc, FRCP
Contracted research: NPS Pharmaceuticals, Inc.

Carol Rees Parrish, MS, RD
Ownership interest (stocks/stock options – excluding mutual funds): NPS Pharmaceuticals, Inc.
Other (Publishing): NPS Pharmaceuticals, Inc.

James S. Scolapio, MD, has indicated no real or apparent conflicts.

The activity planners and peer reviewers have no financial relationships to disclose.

Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.

Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.

Disclaimer
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

ADA Statement
Med-IQ fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Med-IQ at 443 543 5200.

Hardware/Software Requirements
Operating System
Microsoft Windows® 2000, XP, Vista
Mac OS 10.1 or later

Browser
Microsoft Internet Explorer 6.0 or later

Mozilla Firefox 5.0 or later
Download: http://www.mozilla.org/en-US/firefox/new/

Google Chrome
Download: http://www.google.com/chrome

Apple Safari
Download: http://www.apple.com/safari/download/

PDF Viewer
Adobe Acrobat Reader® or Adobe Reader
Download: http://get.adobe.com/reader/

Adobe Flash Player
Adobe Flash Player 9 or later
Download: http://get.adobe.com/flashplayer/

Connection Type
High bandwidth (300k) is strongly recommended
Low bandwidth (100k) results in less than optimal quality
Dial-up/modem is not recommended

For technical support, go to https://www.med-iq.com/index.cfm?fuseaction=content.support.

Contact Information
Comments about today’s program?
Call toll-free 866 858 7434 or e-mail info@med-iq.com

Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy notice, please visit: www.Med-IQ.com/privacy-statement/.

Acknowledgment of Commercial Support
This activity is supported by an educational grant from NPS Pharmaceuticals, Inc.

Copyright
© 2013 Med-IQ®. All rights reserved.

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or email info@med-iq.com. For technical assistance, please refer to our support manual.